Date | Price Target | Rating | Analyst |
---|---|---|---|
2/29/2024 | Mkt Perform → Outperform | William Blair | |
9/15/2023 | $53.00 | Neutral | UBS |
11/25/2022 | Outperform → Mkt Perform | William Blair | |
6/23/2021 | $57.00 → $65.00 | Neutral | Credit Suisse |
6/23/2021 | $78.00 → $89.00 | Outperform | Baird |
4 - KORN FERRY (0000056679) (Issuer)
4 - KORN FERRY (0000056679) (Issuer)
4 - KORN FERRY (0000056679) (Issuer)
Korn Ferry (NYSE:KFY) has been named one of the "Top 80 Companies for Executive Women" in 2024 by Seramount. The list highlights the top workplaces for women who want to advance their careers and celebrates companies that champion women's achievements. "We are honored to be recognized for the fifth year in a row by Seramount as a top company for executive women," said Linda Hyman, Korn Ferry Executive Vice President of Global Human Resources. "Korn Ferry is committed to fostering an inclusive environment where female professionals, and all global colleagues, can thrive and succeed. I am proud of our culture, programs, and the opportunities we offer and look forward to continued progress."
Highlights Korn Ferry reports Q1 FY'25 fee revenue of $674.9 million, a year-over-year decrease of 3% (down 2% on a constant currency basis). Executive Search fee revenue grew 2% year-over-year (up 3% at constant currency). Fee revenue for Consulting and Digital was flat year-over-year (up 1% and 2%, respectively, at constant currency), continuing to demonstrate stability in a challenging market. Net income attributable to Korn Ferry was $62.6 million, while diluted and adjusted diluted earnings per share were $1.17 and $1.18 in Q1 FY'25, respectively. Operating income was $76.1 million and Adjusted EBITDA was $111.2 million. Operating margin increased 320bps year-over-y
Korn Ferry (NYSE:KFY) today announced that the firm will release financial results for the first quarter of fiscal year 2025 (ended July 31, 2024) on Thursday, September 5, 2024. A press release will be issued before the market opens on Thursday, September 5, 2024 followed by a live webcast at 12:00 pm EDT. What: Korn Ferry to Report Q1 FY2025 Earnings Investor Live Webcast When: 12:00 pm EDT on Thursday, September 5, 2024 Where: Live audio webcast and accompanying slides will be available at the following site: https://ir.kornferry.com/events-and-presentations About Korn Ferry Korn Ferry is a global organizational consulting firm. We work with our clients to design optimal orga
10-Q - KORN FERRY (0000056679) (Filer)
8-K - KORN FERRY (0000056679) (Filer)
DEF 14A - KORN FERRY (0000056679) (Filer)
William Blair upgraded Korn/Ferry from Mkt Perform to Outperform
UBS initiated coverage of Korn/Ferry with a rating of Neutral and set a new price target of $53.00
William Blair downgraded Korn/Ferry from Outperform to Mkt Perform
SC 13G/A - KORN FERRY (0000056679) (Subject)
SC 13G/A - KORN FERRY (0000056679) (Subject)
SC 13G/A - KORN FERRY (0000056679) (Subject)
Highlights Korn Ferry reports Q1 FY'25 fee revenue of $674.9 million, a year-over-year decrease of 3% (down 2% on a constant currency basis). Executive Search fee revenue grew 2% year-over-year (up 3% at constant currency). Fee revenue for Consulting and Digital was flat year-over-year (up 1% and 2%, respectively, at constant currency), continuing to demonstrate stability in a challenging market. Net income attributable to Korn Ferry was $62.6 million, while diluted and adjusted diluted earnings per share were $1.17 and $1.18 in Q1 FY'25, respectively. Operating income was $76.1 million and Adjusted EBITDA was $111.2 million. Operating margin increased 320bps year-over-y
Fourth Quarter and Full Year Highlights Korn Ferry reports Q4 FY'24 fee revenue of $690.8 million, a year-over-year decrease of 5% in both actual and constant currency and full year FY'24 fee revenue of $2,762.7 million, a year-over-year decrease of 3% in both actual and constant currency. Our full year FY'24 Marquee and Regional Account fee revenue generated slightly more than 37% of our consolidated fee revenue and grew 3% year-over-year at actual, and 2% at constant currency. Net income attributable to Korn Ferry for the fourth quarter and full year of FY'24 was $65.2 million and $169.2 million, respectively, while diluted and adjusted diluted earnings per share were $1.24 and $
Highlights Korn Ferry reports Q3 FY'24 fee revenue of $668.7 million, a year-over-year decrease of 2% at both actual and constant currency. Net income attributable to Korn Ferry was $59.1 million, while diluted and adjusted diluted earnings per share were $1.13 and $1.07 in Q3 FY'24, respectively. Operating income was $49.9 million with an operating margin of 7.5%, a 570bps increase compared to year-ago quarter, and Adjusted EBITDA was $101.7 million with an Adjusted EBITDA margin of 15.2%, a 110bps increase compared to year-ago quarter. Consulting and Digital continued to show resilient business operations: Consulting fee revenue grew 3% year-over-year with a 12% increase in
These mid-cap stocks were the best performers in the last week. Are they in your portfolio? Avidity Biosciences, Inc. (NASDAQ:RNA) shares jumped 50.15% following the announcement that the Phase 1/2 trial data for muscle disorder therapy yielded positive results. Iris Energy Limited (NASDAQ:IREN) shares surged 24.31% after Cantor Fitzgerald assumed an Overweight rating on the stock and announced a $23 price target. Hims & Hers Health, Inc. (NYSE:HIMS) shares rose 15.29%. John Wiley & Sons, Inc. (NYSE:WLY) shares rose 14.07% after the company reported Q4 adjusted EPS and sales that beat estimates. Element Solutions Inc. (NYSE:ESI) shares grew 13.46% after the company raised Q
Truist Securities analyst Tobey Sommer reiterates Korn Ferry (NYSE:KFY) with a Buy and raises the price target from $74 to $78.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co. raised the price target for UroGen Pharma Ltd. (NASDAQ:URGN) from $54 to $60. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating. UroGen Pharma shares jumped 37.6% to close at $17.50 on Thursday. See how other analysts view this stock. Keybanc raised the price target for Adobe Inc. (NASDAQ:ADBE) from $445 to $450. Keybanc analyst Jackson Ader maintained an Underweight rating. Adobe shares fell 0.3% to close at $458.74 on Thursday. See how other analysts view
Korn Ferry (NYSE:KFY), a global organizational consulting firm, today announced that it has appointed Jeanne MacDonald as Chief Executive Officer, Recruitment Process Outsourcing (RPO) and Mathias Herzog will assume leadership of the firm's Digital Solution. "Jeanne and Mathias are proven executives, and we are thrilled to have people of their caliber lead these offerings," said Gary D. Burnison, CEO, Korn Ferry. "Jeanne is the natural choice to lead RPO after years of overseeing Global RPO Solutions and playing a fundamental role in the business's commercial and financial success. Mathias brings in-depth consulting and technology expertise that will help further the digitization of our o
Korn Ferry (NYSE:KFY) today announced the election of a new member to its Board of Directors, in addition to the appointment of a new Non-Executive Chair. Charles Harrington joins as a Board Director. Christina Gold, who has served on the firm's Board since 2014, and most recently as the Non-Executive Chair since 2019, retires from the Board. Current Board member Jerry Leamon succeeds Ms. Gold as Non-Executive Chair as part of a planned succession. George Shaheen retires from the Board after more than 12 years of total service, including as Non-Executive Chair from 2012 to 2019. Harrington brings to Korn Ferry's Board extensive experience in strategy development and execution, tra